Economic evidence for the prevention and treatment of atopic eczema: A protocol for a systematic review

被引:6
|
作者
Sach T.H. [1 ]
McManus E. [1 ]
Mcmonagle C. [1 ]
Levell N. [2 ]
机构
[1] University of East Anglia, Health Economics Group, Norwich Medical School, Norwich
[2] Norfolk and Norwich University Hospitals NHS Foundation Trust, Dermatology Department, Colney Lane, Norwich
关键词
Cost effectiveness; Costs; Economics; Eczema; Health-related quality of life;
D O I
10.1186/s13643-016-0262-0
中图分类号
学科分类号
摘要
Background: Eczema, synonymous with atopic eczema or atopic dermatitis, is a chronic skin disease that has a similar impact on health-related quality of life as other chronic diseases. The proposed research aims to provide a comprehensive systematic assessment of the economic evidence base available to inform economic modelling and decision making on interventions to prevent and treat eczema at any stage of the life course. Whilst the Global Resource of Eczema Trials (GREAT) database collects together the effectiveness evidence for eczema, there is currently no such systematic resource on the economics of eczema. It is important to gain an overview of the current state of the art of economic methods in the field of eczema in order to strengthen the economic evidence base further. Methods/design: The proposed study is a systematic review of the economic evidence surrounding interventions for the prevention and treatment of eczema. Relevant search terms will be used to search MEDLINE, EMBASE, Database of Abstracts of Reviews of Effects, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, National Health Service (NHS) Economic Evaluation Database, Health Technology Assessment, Cumulative Index to Nursing and Allied Health Literature, EconLit, Scopus, Cost-Effectiveness Analysis Registry and Web of Science in order to identify relevant evidence. To be eligible for inclusion studies will be primary empirical studies evaluating the cost, utility or full economic evaluation of interventions for preventing or treating eczema. Two reviewers will independently assess studies for eligibility and perform data abstraction. Evidence tables will be produced presenting details of study characteristics, costing methods, outcome methods and quality assessment. The methodological quality of studies will be assessed using accepted checklists. Discussion: The systematic review is being undertaken to identify the type of economic evidence available, summarise the results of the available economic evidence and critically appraise the quality of economic evidence currently available to inform future economic modelling and resource allocation decisions about interventions to prevent or treat eczema. We aim to use the review to offer guidance about how to gather economic evidence in studies of eczema and/or what further research is necessary in order to inform this. Systematic review registration: PROSPERO CRD42015024633 © 2016 Sach et al.
引用
收藏
相关论文
共 50 条
  • [31] Clinical evidence - Atopic eczema
    Charman, C
    BMJ-BRITISH MEDICAL JOURNAL, 1999, 318 (7198): : 1600 - 1604
  • [32] BREAST FEEDING AND PREVENTION OF ATOPIC ECZEMA
    CHANDRA, RK
    PEDIATRIC RESEARCH, 1978, 12 (04) : 478 - 478
  • [33] Induction, treatment and prevention of eczema vaccinatum in atopic dermatitis mouse models
    Achdout, Hagit
    Lustig, Shlomo
    Israely, Tomer
    Erez, Noam
    Politi, Boaz
    Tamir, Hadas
    Israeli, Ofir
    Waner, Trevor
    Melamed, Sharon
    Paran, Nir
    VACCINE, 2017, 35 (33) : 4245 - 4254
  • [34] Microbiome modulators for atopic eczema: a systematic review of experimental and investigational therapeutics
    Greenzaid, Jonathan D.
    Chan, Lina J.
    Chandani, Brittany M.
    Kiritsis, Nicholas R.
    Feldman, Steven R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2024, 33 (04) : 415 - 430
  • [35] Risk of developing asthma in young children with atopic eczema: A systematic review
    van der Hulst, Annelies E.
    Klip, Helen
    Brand, Paul L. P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (03) : 565 - 569
  • [36] Cochrane systematic review: interventions to reduce Staphylococcus aureus in atopic eczema
    Birnie, A. J.
    Bath-Hextall, F.
    Ravenscroft, J. C.
    Williams, H. C.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (06) : 1241 - 1241
  • [37] A REVIEW OF THE ECONOMIC EVIDENCE ON PREVENTION
    SCHEFFLER, RM
    PARINGER, L
    MEDICAL CARE, 1980, 18 (05) : 473 - 484
  • [38] Tuina for treatment of atopic eczema in children under 14 years: A systematic review of randomized controlled trials
    Chunli Lu
    Xinyan Jin
    Darong Wu
    Sijia Zhu
    Lily Lai
    Jianping Liu
    Journal of Traditional Chinese Medical Sciences, 2019, 6 (01) : 13 - 25
  • [39] Measurement properties of measures of health-related quality of life measurement instruments for atopic eczema: protocol for a systematic review
    Apfelbacher, C.
    Deckert, S.
    Ofenloch, R.
    Schmitt, J.
    BRITISH JOURNAL OF DERMATOLOGY, 2014, 170 (06) : E39 - E40
  • [40] Farm living and risk of asthma, atopic eczema, respiratory and food allergy: protocol for a systematic review and meta-analysis
    Kuya, Johnstone
    Omoronyia, Ogban
    Fokukora, Theopista
    Emmanuel, Aduroja Posi
    Ewemooje, Olusegun Sunday
    Soyege, Adewumni O.
    Ngo, Valery
    Anyiam, Felix Emeka
    Ackah, Josephine Akua
    Ossai-Chidi, Linus
    Manuel, Beatriz
    Okondu, Ogechukwu Emmanuel
    Nwaru, Bright, I
    BMJ OPEN, 2021, 11 (12):